Summary
According to APO Research, The global Genetic Disease Diagnostic market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Genetic Disease Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Genetic Disease Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Genetic Disease Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Genetic Disease Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Genetic Disease Diagnostic, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Genetic Disease Diagnostic, also provides the revenue of main regions and countries. Of the upcoming market potential for Genetic Disease Diagnostic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genetic Disease Diagnostic revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Genetic Disease Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Genetic Disease Diagnostic revenue, projected growth trends, production technology, application and end-user industry.
Genetic Disease Diagnostic segment by Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Genetic Disease Diagnostic segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Genetic Disease Diagnostic segment by Application
Hospital
Medical Laboratory
Others
Genetic Disease Diagnostic segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disease Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetic Disease Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disease Diagnostic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Genetic Disease Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Genetic Disease Diagnostic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetic Disease Diagnostic revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Genetic Disease Diagnostic Market by Type
1.2.1 Global Genetic Disease Diagnostic Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Genetic Disease Diagnostic Market by Application
1.3.1 Global Genetic Disease Diagnostic Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Genetic Disease Diagnostic Market Dynamics
2.1 Genetic Disease Diagnostic Industry Trends
2.2 Genetic Disease Diagnostic Industry Drivers
2.3 Genetic Disease Diagnostic Industry Opportunities and Challenges
2.4 Genetic Disease Diagnostic Industry Restraints
3 Global Growth Perspective
3.1 Global Genetic Disease Diagnostic Market Perspective (2019-2030)
3.2 Global Genetic Disease Diagnostic Growth Trends by Region
3.2.1 Global Genetic Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Genetic Disease Diagnostic Market Size by Region (2019-2024)
3.2.3 Global Genetic Disease Diagnostic Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Genetic Disease Diagnostic Revenue by Players
4.1.1 Global Genetic Disease Diagnostic Revenue by Players (2019-2024)
4.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2019-2024)
4.1.3 Global Genetic Disease Diagnostic Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Genetic Disease Diagnostic Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Genetic Disease Diagnostic Key Players Headquarters & Area Served
4.4 Global Genetic Disease Diagnostic Players, Product Type & Application
4.5 Global Genetic Disease Diagnostic Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Genetic Disease Diagnostic Market CR5 and HHI
4.6.2 Global Top 5 and 10 Genetic Disease Diagnostic Players Market Share by Revenue in 2023
4.6.3 2023 Genetic Disease Diagnostic Tier 1, Tier 2, and Tier 3
5 Genetic Disease Diagnostic Market Size by Type
5.1 Global Genetic Disease Diagnostic Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Genetic Disease Diagnostic Revenue by Type (2019-2030)
5.3 Global Genetic Disease Diagnostic Revenue Market Share by Type (2019-2030)
6 Genetic Disease Diagnostic Market Size by Application
6.1 Global Genetic Disease Diagnostic Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Genetic Disease Diagnostic Revenue by Application (2019-2030)
6.3 Global Genetic Disease Diagnostic Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Comapny Information
7.1.2 Abbott Business Overview
7.1.3 Abbott Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Genetic Disease Diagnostic Product Portfolio
7.1.5 Abbott Recent Developments
7.2 PerkinElmer
7.2.1 PerkinElmer Comapny Information
7.2.2 PerkinElmer Business Overview
7.2.3 PerkinElmer Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.2.4 PerkinElmer Genetic Disease Diagnostic Product Portfolio
7.2.5 PerkinElmer Recent Developments
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Comapny Information
7.3.2 Roche Diagnostics Business Overview
7.3.3 Roche Diagnostics Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.3.4 Roche Diagnostics Genetic Disease Diagnostic Product Portfolio
7.3.5 Roche Diagnostics Recent Developments
7.4 Bio Rad
7.4.1 Bio Rad Comapny Information
7.4.2 Bio Rad Business Overview
7.4.3 Bio Rad Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.4.4 Bio Rad Genetic Disease Diagnostic Product Portfolio
7.4.5 Bio Rad Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Comapny Information
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Product Portfolio
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 BGI Group
7.6.1 BGI Group Comapny Information
7.6.2 BGI Group Business Overview
7.6.3 BGI Group Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.6.4 BGI Group Genetic Disease Diagnostic Product Portfolio
7.6.5 BGI Group Recent Developments
7.7 Berry Genomics
7.7.1 Berry Genomics Comapny Information
7.7.2 Berry Genomics Business Overview
7.7.3 Berry Genomics Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.7.4 Berry Genomics Genetic Disease Diagnostic Product Portfolio
7.7.5 Berry Genomics Recent Developments
7.8 Da An Gene Co., Ltd.
7.8.1 Da An Gene Co., Ltd. Comapny Information
7.8.2 Da An Gene Co., Ltd. Business Overview
7.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Product Portfolio
7.8.5 Da An Gene Co., Ltd. Recent Developments
7.9 Illumina
7.9.1 Illumina Comapny Information
7.9.2 Illumina Business Overview
7.9.3 Illumina Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.9.4 Illumina Genetic Disease Diagnostic Product Portfolio
7.9.5 Illumina Recent Developments
7.10 CapitalBio Technology
7.10.1 CapitalBio Technology Comapny Information
7.10.2 CapitalBio Technology Business Overview
7.10.3 CapitalBio Technology Genetic Disease Diagnostic Revenue and Gross Margin (2019-2024)
7.10.4 CapitalBio Technology Genetic Disease Diagnostic Product Portfolio
7.10.5 CapitalBio Technology Recent Developments
8 North America
8.1 North America Genetic Disease Diagnostic Revenue (2019-2030)
8.2 North America Genetic Disease Diagnostic Revenue by Type (2019-2030)
8.2.1 North America Genetic Disease Diagnostic Revenue by Type (2019-2024)
8.2.2 North America Genetic Disease Diagnostic Revenue by Type (2025-2030)
8.3 North America Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
8.4 North America Genetic Disease Diagnostic Revenue by Application (2019-2030)
8.4.1 North America Genetic Disease Diagnostic Revenue by Application (2019-2024)
8.4.2 North America Genetic Disease Diagnostic Revenue by Application (2025-2030)
8.5 North America Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
8.6 North America Genetic Disease Diagnostic Revenue by Country
8.6.1 North America Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Genetic Disease Diagnostic Revenue by Country (2019-2024)
8.6.3 North America Genetic Disease Diagnostic Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Genetic Disease Diagnostic Revenue (2019-2030)
9.2 Europe Genetic Disease Diagnostic Revenue by Type (2019-2030)
9.2.1 Europe Genetic Disease Diagnostic Revenue by Type (2019-2024)
9.2.2 Europe Genetic Disease Diagnostic Revenue by Type (2025-2030)
9.3 Europe Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
9.4 Europe Genetic Disease Diagnostic Revenue by Application (2019-2030)
9.4.1 Europe Genetic Disease Diagnostic Revenue by Application (2019-2024)
9.4.2 Europe Genetic Disease Diagnostic Revenue by Application (2025-2030)
9.5 Europe Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
9.6 Europe Genetic Disease Diagnostic Revenue by Country
9.6.1 Europe Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Genetic Disease Diagnostic Revenue by Country (2019-2024)
9.6.3 Europe Genetic Disease Diagnostic Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Genetic Disease Diagnostic Revenue (2019-2030)
10.2 China Genetic Disease Diagnostic Revenue by Type (2019-2030)
10.2.1 China Genetic Disease Diagnostic Revenue by Type (2019-2024)
10.2.2 China Genetic Disease Diagnostic Revenue by Type (2025-2030)
10.3 China Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
10.4 China Genetic Disease Diagnostic Revenue by Application (2019-2030)
10.4.1 China Genetic Disease Diagnostic Revenue by Application (2019-2024)
10.4.2 China Genetic Disease Diagnostic Revenue by Application (2025-2030)
10.5 China Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Genetic Disease Diagnostic Revenue (2019-2030)
11.2 Asia Genetic Disease Diagnostic Revenue by Type (2019-2030)
11.2.1 Asia Genetic Disease Diagnostic Revenue by Type (2019-2024)
11.2.2 Asia Genetic Disease Diagnostic Revenue by Type (2025-2030)
11.3 Asia Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
11.4 Asia Genetic Disease Diagnostic Revenue by Application (2019-2030)
11.4.1 Asia Genetic Disease Diagnostic Revenue by Application (2019-2024)
11.4.2 Asia Genetic Disease Diagnostic Revenue by Application (2025-2030)
11.5 Asia Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
11.6 Asia Genetic Disease Diagnostic Revenue by Country
11.6.1 Asia Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Genetic Disease Diagnostic Revenue by Country (2019-2024)
11.6.3 Asia Genetic Disease Diagnostic Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Genetic Disease Diagnostic Revenue (2019-2030)
12.2 MEALA Genetic Disease Diagnostic Revenue by Type (2019-2030)
12.2.1 MEALA Genetic Disease Diagnostic Revenue by Type (2019-2024)
12.2.2 MEALA Genetic Disease Diagnostic Revenue by Type (2025-2030)
12.3 MEALA Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
12.4 MEALA Genetic Disease Diagnostic Revenue by Application (2019-2030)
12.4.1 MEALA Genetic Disease Diagnostic Revenue by Application (2019-2024)
12.4.2 MEALA Genetic Disease Diagnostic Revenue by Application (2025-2030)
12.5 MEALA Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
12.6 MEALA Genetic Disease Diagnostic Revenue by Country
12.6.1 MEALA Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Genetic Disease Diagnostic Revenue by Country (2019-2024)
12.6.3 MEALA Genetic Disease Diagnostic Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Genetic Disease Diagnostic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Prenatal Diagnosis Major Manufacturers
Table 2. Screening for Single Gene Genetic Disease Major Manufacturers
Table 3. Preimplantation Genetic Testing Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Genetic Disease Diagnostic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Hospital Major Manufacturers
Table 7. Medical Laboratory Major Manufacturers
Table 8. Others Major Manufacturers
Table 9. Genetic Disease Diagnostic Industry Trends
Table 10. Genetic Disease Diagnostic Industry Drivers
Table 11. Genetic Disease Diagnostic Industry Opportunities and Challenges
Table 12. Genetic Disease Diagnostic Industry Restraints
Table 13. Global Genetic Disease Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Genetic Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Genetic Disease Diagnostic Market Share by Region (2019-2024)
Table 16. Global Genetic Disease Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Genetic Disease Diagnostic Market Share by Region (2025-2030)
Table 18. Global Genetic Disease Diagnostic Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Genetic Disease Diagnostic Revenue Market Share by Players (2019-2024)
Table 20. Global Genetic Disease Diagnostic Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Genetic Disease Diagnostic Key Players Headquarters & Area Served
Table 22. Global Genetic Disease Diagnostic Players, Product Type & Application
Table 23. Global Genetic Disease Diagnostic Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Genetic Disease Diagnostic by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Genetic Disease Diagnostic Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Genetic Disease Diagnostic Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Genetic Disease Diagnostic Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Genetic Disease Diagnostic Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Genetic Disease Diagnostic Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Genetic Disease Diagnostic Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Genetic Disease Diagnostic Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Genetic Disease Diagnostic Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Genetic Disease Diagnostic Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Genetic Disease Diagnostic Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. Abbott Company Information
Table 37. Abbott Business Overview
Table 38. Abbott Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. Abbott Genetic Disease Diagnostic Product Portfolio
Table 40. Abbott Recent Development
Table 41. PerkinElmer Company Information
Table 42. PerkinElmer Business Overview
Table 43. PerkinElmer Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. PerkinElmer Genetic Disease Diagnostic Product Portfolio
Table 45. PerkinElmer Recent Development
Table 46. Roche Diagnostics Company Information
Table 47. Roche Diagnostics Business Overview
Table 48. Roche Diagnostics Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Roche Diagnostics Genetic Disease Diagnostic Product Portfolio
Table 50. Roche Diagnostics Recent Development
Table 51. Bio Rad Company Information
Table 52. Bio Rad Business Overview
Table 53. Bio Rad Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. Bio Rad Genetic Disease Diagnostic Product Portfolio
Table 55. Bio Rad Recent Development
Table 56. Thermo Fisher Scientific Company Information
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Thermo Fisher Scientific Genetic Disease Diagnostic Product Portfolio
Table 60. Thermo Fisher Scientific Recent Development
Table 61. BGI Group Company Information
Table 62. BGI Group Business Overview
Table 63. BGI Group Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. BGI Group Genetic Disease Diagnostic Product Portfolio
Table 65. BGI Group Recent Development
Table 66. Berry Genomics Company Information
Table 67. Berry Genomics Business Overview
Table 68. Berry Genomics Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Berry Genomics Genetic Disease Diagnostic Product Portfolio
Table 70. Berry Genomics Recent Development
Table 71. Da An Gene Co., Ltd. Company Information
Table 72. Da An Gene Co., Ltd. Business Overview
Table 73. Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Da An Gene Co., Ltd. Genetic Disease Diagnostic Product Portfolio
Table 75. Da An Gene Co., Ltd. Recent Development
Table 76. Illumina Company Information
Table 77. Illumina Business Overview
Table 78. Illumina Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. Illumina Genetic Disease Diagnostic Product Portfolio
Table 80. Illumina Recent Development
Table 81. CapitalBio Technology Company Information
Table 82. CapitalBio Technology Business Overview
Table 83. CapitalBio Technology Genetic Disease Diagnostic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. CapitalBio Technology Genetic Disease Diagnostic Product Portfolio
Table 85. CapitalBio Technology Recent Development
Table 86. North America Genetic Disease Diagnostic Revenue by Type (2019-2024) & (US$ Million)
Table 87. North America Genetic Disease Diagnostic Revenue by Application (2019-2024) & (US$ Million)
Table 88. North America Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 89. North America Genetic Disease Diagnostic Revenue by Country (2019-2024) & (US$ Million)
Table 90. North America Genetic Disease Diagnostic Revenue by Country (2025-2030) & (US$ Million)
Table 91. Europe Genetic Disease Diagnostic Revenue by Type (2019-2024) & (US$ Million)
Table 92. Europe Genetic Disease Diagnostic Revenue by Application (2019-2024) & (US$ Million)
Table 93. Europe Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 94. Europe Genetic Disease Diagnostic Revenue by Country (2019-2024) & (US$ Million)
Table 95. Europe Genetic Disease Diagnostic Revenue by Country (2025-2030) & (US$ Million)
Table 96. China Genetic Disease Diagnostic Revenue by Type (2019-2024) & (US$ Million)
Table 97. China Genetic Disease Diagnostic Revenue by Application (2019-2024) & (US$ Million)
Table 98. Asia Genetic Disease Diagnostic Revenue by Type (2019-2024) & (US$ Million)
Table 99. Asia Genetic Disease Diagnostic Revenue by Application (2019-2024) & (US$ Million)
Table 100. Asia Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 101. Asia Genetic Disease Diagnostic Revenue by Country (2019-2024) & (US$ Million)
Table 102. Asia Genetic Disease Diagnostic Revenue by Country (2025-2030) & (US$ Million)
Table 103. MEALA Genetic Disease Diagnostic Revenue by Type (2019-2024) & (US$ Million)
Table 104. MEALA Genetic Disease Diagnostic Revenue by Application (2019-2024) & (US$ Million)
Table 105. MEALA Genetic Disease Diagnostic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 106. MEALA Genetic Disease Diagnostic Revenue by Country (2019-2024) & (US$ Million)
Table 107. MEALA Genetic Disease Diagnostic Revenue by Country (2025-2030) & (US$ Million)
Table 108. Research Programs/Design for This Report
Table 109. Authors List of This Report
Table 110. Secondary Sources
Table 111. Primary Sources
List of Figures
Figure 1. Genetic Disease Diagnostic Product Picture
Figure 2. Global Genetic Disease Diagnostic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Genetic Disease Diagnostic Market Size Share 2019 VS 2023 VS 2030
Figure 4. Prenatal Diagnosis Picture
Figure 5. Screening for Single Gene Genetic Disease Picture
Figure 6. Preimplantation Genetic Testing Picture
Figure 7. Others Picture
Figure 8. Global Genetic Disease Diagnostic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Genetic Disease Diagnostic Market Size Share 2019 VS 2023 VS 2030
Figure 10. Hospital Picture
Figure 11. Medical Laboratory Picture
Figure 12. Others Picture
Figure 13. Global Genetic Disease Diagnostic Market Size (US$ Million) & (2019-2030)
Figure 14. Global Genetic Disease Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Genetic Disease Diagnostic Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Genetic Disease Diagnostic Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Genetic Disease Diagnostic Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Genetic Disease Diagnostic Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Genetic Disease Diagnostic Revenue Market Share by Type (2019-2030)
Figure 21. Global Genetic Disease Diagnostic Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Genetic Disease Diagnostic Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Genetic Disease Diagnostic Revenue Market Share by Application (2019-2030)
Figure 24. North America Genetic Disease Diagnostic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Genetic Disease Diagnostic Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
Figure 27. North America Genetic Disease Diagnostic Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
Figure 29. North America Genetic Disease Diagnostic Revenue Share by Country (2019-2030)
Figure 30. United States Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Genetic Disease Diagnostic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Genetic Disease Diagnostic Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
Figure 35. Europe Genetic Disease Diagnostic Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
Figure 37. Europe Genetic Disease Diagnostic Revenue Share by Country (2019-2030)
Figure 38. Germany Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Genetic Disease Diagnostic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Genetic Disease Diagnostic Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
Figure 47. China Genetic Disease Diagnostic Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
Figure 49. Asia Genetic Disease Diagnostic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Genetic Disease Diagnostic Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
Figure 52. Asia Genetic Disease Diagnostic Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
Figure 54. Asia Genetic Disease Diagnostic Revenue Share by Country (2019-2030)
Figure 55. Japan Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Genetic Disease Diagnostic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Genetic Disease Diagnostic Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Genetic Disease Diagnostic Revenue Share by Type (2019-2030)
Figure 64. MEALA Genetic Disease Diagnostic Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Genetic Disease Diagnostic Revenue Share by Application (2019-2030)
Figure 66. MEALA Genetic Disease Diagnostic Revenue Share by Country (2019-2030)
Figure 67. Mexico Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Genetic Disease Diagnostic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
